Dr. Ramakrishnan is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-4673Fax+1 214-645-2661
Summary
- I am a board certified hematologist-oncologist. I specialize in caring for patients with lymphomas and other hematologic malignancies.
Education & Training
- Sidney Kimmel Medical College at Thomas Jefferson University/TJUHFellowship, Hematology and Medical Oncology, 2014 - 2017
- Albert Einstein Healthcare NetworkResidency, Internal Medicine, 2012 - 2014
- University of Kerala Medical CollegeClass of 2007
Certifications & Licensure
- IL State Medical License 2023 - 2026
- TX State Medical License 2016 - 2025
- PA State Medical License 2011 - 2018
- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Publications & Presentations
PubMed
- 86 citationsNCCN Guidelines® Insights: B-Cell Lymphomas, Version 5.2021.Andrew D. Zelenetz, Leo I. Gordon, Julie E. Chang, Beth Christian, Jeremy S. Abramson
Journal of the National Comprehensive Cancer Network. 2021-11-01 - 25 citationsAllogeneic hematopoietic cell transplantation provides effective salvage despite refractory disease or failed prior autologous transplant in angioimmunoblastic T-cell ...Narendranath Epperla, Kwang Woo Ahn, Carlos Litovich, Sairah Ahmed, Minoo Battiwalla
Journal of Hematology & Oncology. 2019-01-10 - 36 citationsAssociation of Reduced-Intensity Conditioning Regimens With Overall Survival Among Patients With Non-Hodgkin Lymphoma Undergoing Allogeneic TransplantNilanjan Ghosh, Sairah Ahmed, Kwang Woo Ahn, Manoj Khanal, Carlos Litovich
JAMA Oncology. 2020-06-04
Press Mentions
- CAR T-cell Products Among Top Advances in Non-Hodgkin LymphomaJanuary 31st, 2020
- Dr. Ramakrishnan on Benefit of CAR T-cell Therapy in MCLJanuary 22nd, 2020
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: